where is prr going from here, page-4

SP - its all very interesting regarding the approval for manufacturing and in particular I liked this little snippet in the report that stated

"We believe other countries may approve C-Vac as a ‘blood product’, prior to full regulatory approval by the US and EU".

Could this mean other commercial sales before approval?

I cant remember exactly but aren’t there plans to manufacture CVac in other countries as well (was it NZ) ?

Im only guessing but would someone be kind enough enlighten us perhaps?

If these sales do commence prior to approval it would certainly add a nice little revenue stream to the company and reduce the cash burn.

Good luck everyone